Quest Diagnostics Raises Full-Year Guidance Following Strong Q3 Revenue and EPS Growth
Quest Diagnostics (DGX) reported strong third-quarter performance, highlighted by a 10% increase in revenue and an adjusted earnings per share (EPS) growth exceeding 15%. Driven by these results, CEO James Davis announced that the company is raising its full-year guidance for both total revenues and earnings per share. The company's outlook remains optimistic, with management projecting significant expansion in its consumer health segment, which is expected to grow at a rate exceeding 30%. This growth trajectory underscores a strategic shift toward direct-to-consumer diagnostic services alongside traditional clinical testing.
Tickers: $DGX
Topics: earnings report guidance increase revenue growth
Read the full article at Seeking Alpha
Part of the story Hasbro Raises Full-Year Outlook Amid Strong Q3 Performance and Strategic Growth Initiatives (6 articles)